GWS
BMY.RT

Glassman Wealth Services’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Glassman Wealth Services’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-162
Closed – – 1727
2020
Q4 		$0 Sell
162
-204
-56% -$435 ﹤0.01% 1590
2020
Q3 		$1K Hold
366
– – ﹤0.01% 1296
2020
Q2 		$1K Sell
366
-758
-67% -$2.73K ﹤0.01% 1177
2020
Q1 		$4K Hold
1,124
– – ﹤0.01% 581
2019
Q4 		$3K Buy
+1,124
New +$2.92K ﹤0.01% 712

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Glassman Wealth Services's BMY.RT Position: Q1 2021 in Review

Glassman Wealth Services sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 162 shares.

Glassman Wealth Services first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $4K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Glassman Wealth Services reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Glassman Wealth Services sold 162 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • Glassman Wealth Services first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Glassman Wealth Services's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $4K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Glassman Wealth Services's 13F filing for Q1 2021, filed 5 May 2021.